necessity of retention samples for pilot BE study [Regulatives / Guidelines]

posted by nobody – 2019-11-26 10:11 (537 d 12:39 ago) – Posting: # 20872
Views: 1,553

» My angle on this was related. FDA recently issued a PSG for Beclo/Calcipotriol introducing the need for a pilot trial.

This is this occult skin bleaching (vasocontrictor) test, here you don't "ship" any samples at all.

Ladies, these backup samples are for reproducing results in case the primary analysis is fishy. And to stop labs from making up studies and results completely (with mixed results on this part). I would keep this in mind when planning a trial.

If you are in doubt, start a controlled correspondence with the-one-not-to-be-named (aka USA-FDA-Trump-whatever...)

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 9 (0 registered, 9 guests [including 2 identified bots]).
Forum time: Sunday 23:50 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5